Out in the cold
Is pharma missing a trick by sidestepping academics for medical and scientific liaison (MSL) roles?
PharmaTimes Magazine
PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital versions have a total circulation of 23,184, reaching right across the industry into every company and every function. What's more, our circulation includes 8,000 NHS healthcare professionals: chief pharmacists, medicines management and primary care commissioners.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
View more from the latest edition
Radically digital
How COVID-19 will change the future of healthcare
Cancer: a new patient-centric ecosystem
Kulveer Singh looks at what’s needed to support a new patient-centric cancer care ecosystem for successful treatment and management of the disease
Fair game
The continuing challenges of competition law for the pharma sector
Biomarkers and a battle of the bases
Why RNA is the future of diagnostics
The perfect storm
Defining the gaps in antibiotic pandemic preparedness
Pressing ahead
3D bioprinting pushes the bounds of human tissue engineering
Care in the home
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are increasingly being empowered to manage their conditions at home
